Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
Recruiting
Phase 2
Interventional Study
Post-Concussion Syndrome
Concussion, Brain
Mild Traumatic Brain Injury
Head Injury
Headache
Dizziness
Cognitive Symptom
Dysautonomia
Anxiety
Irritability; Syndrome
Depression
Post-traumatic Stress Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 75 (estimated)
- Sponsor
- University of California, Los Angeles · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to investigate a new treatment for chronic symptoms after concussion or mild traumatic brain injury in people aged 18-65 years old. Chronic symptoms could include dizziness, headache, fatigue, brain fog, memory difficulty, sleep disruption, irritability, or anxiety that occurred or worsened after the injury. These symptoms can interfere with daily functioning, causing dif…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Mild traumatic brain injury (mTBI) defined in accord with the World Health Organization criteria in the last 12 months
* age 18-65 at the time of the mTBI
* high burden of post-concussive symptoms defined as a score \>=20 on the Rivermead Post-Concussion Symptoms Questionnaire…
Contacts